DSIP / BPC-157 / CJC Combination Peptide Screening Form Template

This combination screening form is designed for patients being evaluated for a multi-peptide protocol incorporating DSIP (sleep/stress modulation), BPC-157 (tissue repair and inflammation), and CJC-1295 or Ipamorelin (growth hormone support). Combination peptide protocols require a consolidated screening approach to capture symptoms across all therapeutic targets while documenting all relevant contraindications. Use this form when a patient is being considered for two or more of these peptides simultaneously.

4 sections
17 fields
HIPAA-ready
3 citations

Free Template

DSIP / BPC-157 / CJC Combination Screening Form

Preview Form Automate This Form
No account required to use template
Customize with your practice branding
Reviewed against HIPAA & DEA guidelines

Form Preview

This is how the form appears to patients. Customize with your practice name and branding.

Your Practice Name

DSIP / BPC-157 / CJC Combination Screening Form

Preview
1

General Patient Information

Please provide your personal information.

First Name

Jane

Last Name

Smith

Date of Birth

Can you confirm you are 18 years or older?

Height

e.g. 5'8"

Weight

e.g. 170 lbs

2

Medical History

Please answer all questions as accurately as possible. Your provider will review this information.

Are you actively taking any medications? If so, please list them.

List all current medications, dosages, and frequencies

Do you have any medication allergies? If so, please list them.

List all known drug allergies and reactions

Are you currently being treated or have you been treated for any medical conditions? If so, please list them.

List all current and past medical conditions

Have you had any past surgeries? If so, please list them.

List all surgeries and approximate dates

What is/was your sex assigned at birth?

Male

Emergency contact name and phone number

Name — (555) 000-0000

Mailing address

123 Main St, City, State, ZIP

Any other questions or concerns?

Optional — share anything else you'd like your provider to know

3

Symptoms

Select all symptoms that currently apply to you.

Which of the following symptoms are you experiencing?
4

Medical Conditions

Select all conditions that currently apply to you.

Do any of the following apply to you?

Preview only. Your live form will include your branding and e-signature capture.

Submit

Compliance & Regulatory Notes

Review these notes before deploying this form in your practice.

Each peptide in a combination protocol is prescribed off-label. A single informed consent form should list each peptide individually. See FSMB off-label guidance: https://www.fsmb.org

Patients on CNS-active medications, anticoagulants, or immunosuppressants require careful review before initiating any peptide combination.

All peptides must be dispensed by a licensed compounding pharmacy. Verify current FDA compounding status for each peptide. See FDA: https://www.fda.gov/drugs/human-drug-compounding

Want This Form Automated?

Karpa Health turns static intake forms into a fully automated clinical workflow. Branded, HIPAA-compliant, and connected to compounding pharmacies.

  • Branded intake on your website
  • AI contraindication screening
  • One-click prescribing to pharmacies
  • Automated refill management
  • E-signatures and HIPAA audit trail
  • 50-state provider network included
Book a Demo

Free 30-minute walkthrough

Sources & References

  1. FDA Human Drug Compounding Guidance
  2. FSMB Off-Label Prescribing Guidelines
  3. PCAB Compounding Pharmacy Accreditation

Frequently Asked Questions

Why use a combination screening form instead of separate forms?

When a patient is being evaluated for multiple peptides in one protocol, a single consolidated screening form is more efficient and captures overlapping contraindications in one review. Separate forms may be used if peptides are initiated at different times.

Are there additional risks with peptide combinations?

Combination protocols may have additive or synergistic effects. Providers should consider all potential drug interactions and overlapping contraindications when prescribing multiple peptides simultaneously.